Skip to content
Menu
Home
About Us
Life Wins
Chairman’s Profile
Board Of Directors
Team Wockhardt
Corporate Milestones
Research & Development
R&D at Wockhardt
New Drug Discovery
Pipeline / Projects
News & Events
Publications
WCK 5222
WCK 4873
WCK 4282
WCK 6777
Biologicals
News & Events
Pipeline / Projects
Publications
R&D Contact
Our Business Verticals
Our Manufacturing Units
Global Footprint
India
UK & Europe
US
Emerging Markets
Products
India Branded Business
Trademark Products
Quality
Digital Footprint
Awards & Recognitions
Investors
From Chairman’s Office
AGM Speech
Letter to Shareowners
Financials
Financials at a Glance
Annual Report
Quarterly Results
Financial Press Releases
Related Party Transactions
Subsidiary Financials
Annual Return
Corporate Governance
Policies & Codes
Committee’s of the Board
Familiarisation programs
Shareholding Pattern
Secretarial Compliance Report
Authorised KMP
Corporate Actions
Announcements / Disclosures
Shareholders Meeting/ Postal ballot
AGM Notice
Proceedings
IEPF
Unclaimed Dividend
Nodal Officer
Analyst/ Investors
Presentation
Audio / Video Recording
Transcript
Shareowner Services
FAQ
Green Initiative
Investor Contact
Stock Quotes
Credit Rating
careers
Introduction
Life@Wockhardt
L&D Initiatives
Voice of Wockhardians
The Wockhardian
Career@Wockhardt
Media
Press Release
Media Coverage
Video Coverage
Media Kit
Sustainability
Contact us
Home
/
Investor
/
Page 163
Archives:
Investor
This post type contains { $postTypeName } information
Home
QUARTERLY Reports (Q3)
FINANCIAL RESULTS FY9 Q3
Wockhardt receives US FDA approval for Prostate drug Alfuzosin tablets
For the Quarter Ended 30th September, 2009
Wockhardt receives US FDA approval for Prostate drug Tamsulosin capsules
Wockhardt wins Government of India Patent Award
Wockhardt divests its Veterinary business to Vetoquinol
QUARTERLY Reports (Q2)
FINANCIAL RESULTS FY9 Q2
Wockhardt signs agreements to divest its Nutrition businesses to Abbott
Posts navigation
Previous page
Page
1
…
Page
162
Page
163
Page
164
…
Page
170
Next page
